Ixazomib as postinduction maintenance for patients with newly diagnosed multiple myeloma not undergoing autologous stem cell transplantation : The phase III TOURMALINE-MM4 trial
Dimopoulos, Meletios (The National and Kapodistrian University of Athens)
Špička, I. (Charles University. Faculty of Medicine in Hradec Králové)
Quach, H. (St Vincent's Hospital (Sydney))
Oriol, Albert (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Hájek, R. (Department of Hemato-oncology. University Hospital Ostrava. University of Ostrava. Faculty of Medicine)
Garg, M. (Leicester General Hospital (Leicester, Regne Unit))
Beksac, Meral (Department of Hematology. Ankara University)
Bringhen, S. (Azienda Ospedaliero Universitaria Città della Salute e della Scienza (Torí, Itàlia))
Katodritou, E. (Department of Hematology. Theagenion Cancer Hospital)
Chng, W. J. (Department of Hematology-Oncology. National University Cancer Institute. National University Health System. Yong Loo Lin School of Medicine. Cancer Science Institute of Singapore. National University of Singapore)
Leleu, Xavier (Pôle Régional de Cancérologie. Department of Haematology. Centre Hospitalier Universitaire La Milétrie-Poitiers)
Iida, Shinsuke (Department of Hematology and Oncology. Nagoya City University. Graduate School of Medical Sciences)
Mateos, M. V. (Hospital Universitario de Salamanca. Centro de Investigación del Cáncer)
Morgan, G. (New York University. Langone Laura and Isaac Perlmutter Cancer Center)
Vorog, A. (Millennium Pharmaceuticals. Inc.. Takeda Pharmaceutical Company Limited)
Labotka, R. (Millennium Pharmaceuticals. Inc.. Takeda Pharmaceutical Company Limited)
Wang, B. (Millennium Pharmaceuticals. Inc.. Takeda Pharmaceutical Company Limited)
Palumbo, A. (Millennium Pharmaceuticals. Inc.. Takeda Pharmaceutical Company Limited)
Lonial, S. (Department of Hematology and Medical Oncology. Winship Cancer Institute of Emory University)
Universitat Autònoma de Barcelona

Date:	2020
Abstract:	.
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades.
Language:	Anglès
Document:	Article ; recerca ; Versió publicada
Published in:	Journal of clinical oncology, Vol. 38 Núm. 34 (january 2020) , p. 4030-4041, ISSN 1527-7755

DOI: 10.1200/JCO.20.02060
PMID: 33021870

13 p, 861.9 KB

The record appears in these collections:
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Institut d'Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP) > Josep Carreras Leukaemia Research Institute
Articles > Research articles
Articles > Published articles